Cytomegalovirus immune globulin intravenous (Human, MedImmune)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCytomegalovirus immune globulin intravenous (Human, MedImmune)
Drug Alias Name巨细胞病毒人免疫球蛋白Cytomegalovirus immune globulin - MedImmuneCytoGamCMV-IGIV
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationCytomegalovirus Infections
Global Approved IndicationsCytomegalovirus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/04/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Minnesota
Inactive CompaniesGeorge Washington University Biostatistics Center
Active IndicationsRejection of renal transplantationCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB09
Related LinksDrugBank